Back

Amicus Therapeutics Stock Predictions

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Sell

FOLD
Amicus Therapeutics

Last Price:

10.10

Seasonality Move:

8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Amicus Therapeutics Stock Forecast

Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 16% based on the past 17 years of stock performance.
Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
Is Amicus Therapeutics Stock Undervalued?
The current Amicus Therapeutics [FOLD] share price is $10.38. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 16% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Sell

Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

amicusrx.com

52-Week Data

52-Week High:

14.57

52-Week Low:

9.02

Prediction Charts

Market Cap:

3.1B

Price in USD:

10.38

Volume:

2.65M

Beta:

1.02

Technical Analysis

SMA50:

11.06

SMA100:

10.87

SMA200:

11.08

52-Wk Change:

1.07%

Stock Predictions

Is Amicus Therapeutics stock public?
Yes, Amicus Therapeutics is a publicly traded company.
What is the Amicus Therapeutics stock quote today?
The Amicus Therapeutics stock price is 10.38 USD today.
How to buy Amicus Therapeutics stock online?
You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-25	11.79	11.69	11.86	11.63
Oct-28	11.77	11.52	11.85	11.51
Oct-29	11.43	11.49	11.62	11.37
Oct-30	11.38	11.58	11.60	11.37
Oct-31	11.50	11.42	11.53	11.39
Nov-1	11.42	11.47	11.69	11.28
Nov-4	11.45	11.34	11.58	11.24
Nov-5	11.24	11.74	11.75	11.21
Nov-6	12.53	11.23	12.65	10.92
Nov-7	11.24	10.97	11.25	10.73
Nov-8	11.00	10.99	11.36	10.94
Nov-11	11.09	10.69	11.14	10.66
Nov-12	10.69	10.49	10.83	10.43
Nov-13	10.57	10.38	10.66	10.30

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.